Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

377
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
377
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

556
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
556
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

940
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
940
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

141
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
141
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

701
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
701
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

864
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
864

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolation and Genome Characterization of Escherichia Phage vB_EcoA-Sparklingdew.

Genes·2026
Same author

Cardioprotective Effect of <i>Lactobacillus acidophilus</i> and <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> Is Mediated by Sarcolemmal but Not Mitochondrial ATP-Sensitive Potassium Channels in Rats with Systemic Inflammation.

International journal of molecular sciences·2025
Same author

Studying the Oncolytic Activity of <i>Streptococcus pyogenes</i> Strains Against Hepatoma, Glioma, and Pancreatic Cancer <i>In Vitro</i> and <i>In Vivo</i>.

Microorganisms·2025
Same author

Glioblastoma Multiforme: Sensitivity to Antimicrobial Peptides LL-37 and PG-1, and Their Combination with Chemotherapy for Predicting the Overall Survival of Patients.

Pharmaceutics·2024
Same author

Autoprobiotics in the Treatment of Patients with Colorectal Cancer in the Early Postoperative Period.

Microorganisms·2024
Same author

Bacterium-like Particles from <i>Corynebacterium pseudodiphtheriticum</i> as Mucosal Adjuvant for the Development of Pneumococcal Vaccines.

Vaccines·2024

Related Experiment Video

Updated: Dec 30, 2025

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
09:20

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

13.0K

What Is Wrong with Enterococcal Probiotics?

Alexander Suvorov1,2

  • 1Institute of Experimental Medicine, Saint-Petersburg, Russia. Alexander_suvorov1@hotmail.com.

Probiotics and Antimicrobial Proteins
|January 20, 2020
PubMed
Summary
This summary is machine-generated.

Enterococci are common bacteria found in the human gut and foods. This paper clarifies the significant differences between pathogenic and probiotic enterococci strains for medical and consumer understanding.

Keywords:
EnterococcusGenomeInfectionProbioticsSafetyTransformation

More Related Videos

Measuring the Effects of Bacteria and Chemicals on the Intestinal Permeability of Caenorhabditis elegans
07:23

Measuring the Effects of Bacteria and Chemicals on the Intestinal Permeability of Caenorhabditis elegans

Published on: December 3, 2019

15.8K
Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
08:34

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Published on: July 27, 2022

1.2K

Related Experiment Videos

Last Updated: Dec 30, 2025

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
09:20

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

13.0K
Measuring the Effects of Bacteria and Chemicals on the Intestinal Permeability of Caenorhabditis elegans
07:23

Measuring the Effects of Bacteria and Chemicals on the Intestinal Permeability of Caenorhabditis elegans

Published on: December 3, 2019

15.8K
Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
08:34

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Published on: July 27, 2022

1.2K

Area of Science:

  • Microbiology
  • Food Science
  • Medical Science

Background:

  • Enterococci are common human microbiota and food constituents.
  • They are often perceived as pathogens, causing confusion about probiotic use.
  • Distinguishing clinical from probiotic strains is crucial.

Purpose of the Study:

  • To clarify the dual role of enterococci.
  • To differentiate between pathogenic and probiotic strains.
  • To inform medical and public understanding of enterococci.

Main Methods:

  • Review of contemporary molecular microbiology knowledge.
  • Analysis of strain-specific characteristics.
  • Comparison of clinical and probiotic enterococci.

Main Results:

  • Significant molecular and functional differences exist between clinical and probiotic enterococci.
  • Probiotic strains possess beneficial properties distinct from pathogenic ones.
  • Current knowledge supports the safe use of specific enterococcal strains.

Conclusions:

  • Enterococci are not uniformly pathogenic; strain-specific evaluation is key.
  • Probiotic enterococci offer health benefits and are safe for consumption.
  • Molecular microbiology provides the basis for differentiating enterococcal roles.